Introduction
============

The implementation of highly sensitive molecular diagnostic systems in the microbiological diagnostic routine is on the rise. Multiplex polymerase chain reaction (PCR) systems allow the coverage of multiple pathogens in one or several tubes within the same assay and even resistance determinants can be addressed. While increasing standardization and commercialization of such assays allow the reduction of costs and hands-on time, new questions arise regarding the interpretation of the detection of facultative pathogenic microorganisms.

PCR-based assays are usually more expensive but also more sensitive and much faster (**Table [1](#T1){ref-type="table"}**) than culture-based methods as shown, e.g., for enteric bacterial pathogens ([@B66]; [@B49]). This usually increases the quality of diagnosis and offers the possibility of an earlier targeted antimicrobial treatment but may also lead to overdiagnosis, e.g., by the detection of atoxigenic strains, pathogens below the minimum infective dose or the detection of virulence factor genes that are not expressed under the respective conditions.

###### 

Culture-based and culture-independent pathogen detection systems.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Detection system                               Sensitivity                                                                                                           Costs                                                                                                                          Time to result
  ---------------------------------------------- --------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------ ----------------------------------------------------------------------------------------------------------
  **Culture-based pathogen detection**                                                                                                                                                                                                                                                                

  Animal culture                                 Depending on the suitability for the pathogen up to 100%                                                              Varying, usually \>\$100.00 due to time- and labor-intensiveness                                                               Hours to days

  Cell culture                                   Depending on the suitability for the pathogen up to 100%                                                              Varying, usually \$10.00 to \$100.00                                                                                           Days to weeks

  Cell-free culture media                        Depending on the suitability for the pathogen up to 100%                                                              Usually \<\$10.00 if commercially available media are used                                                                     Usually several days

  **Culture-independent pathogen detection**                                                                                                                                                                                                                                                          

  Rapid immune-chromatographic antigen-testing   Test-depending, frequently low\                                                                                       Varying, usually about \$10.00 per test                                                                                        Usually an hour or less
                                                 (70% and less)                                                                                                                                                                                                                                       

  Nucleic acid amplification testing (NAT)       Depending on available copy numbers in the sample; detection limits usually between 10 and 10,000 copies per sample   Less than \$10.00 in case of in-house systems up to several hundred \$ in case of commercial multiplex real-time PCR systems   Less than an hour up to several hours including nucleic acid extraction

  Next generation sequencing (NGS)               Depending on available copy numbers in the sample, usually worse than in case of species- or genus-specific NAT       \>\$1.000 per NGS run                                                                                                          Several days including bio-informatics assessment, less than 2 days in case of automated bio-informatics
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

The impact of resulting difficult interpretative decisions on the microbiological diagnostic routine, i.e., the interpretation of diagnostic results, is exemplarily summarized in the following.

Common Sites of Multiple Pathogen Detections and Interpretative Consequences
============================================================================

Chronic Wounds of Soft Tissue and Skin
--------------------------------------

The causative effect of human chronic wound microbiota in inducing chronic wound infections was recently demonstrated in line with Koch's postulates in the murine model ([@B69]), so etiological causality can be considered as confirmed. Further, biofilms in chronic wounds are believed to trigger chronic infections as shown for associations of chronic periodontitis, atherosclerosis, cardiovascular disease, and diabetes ([@B45]). Mixed-species biofilms affect wound healing considerably more than mono-species biofilms and the combined pathogenicity predicts the clinical cause ([@B54]). This synergistic effect of the bacteria within biofilms is triggered by several mechanisms, comprising, e.g., passive resistance, metabolic cooperation, byproduct influence, quorum sensing systems, and an enlarged gene pool with more efficient DNA sharing ([@B68]). Within multi-species infections in chronic wounds, however, biofilm aggregates of low bacterial diversity and even sovereign monospecies biofilms can be observed ([@B11]).

Frequent pathogens, which are isolated from biofilms of chronic wounds by culture-based approaches, comprise *Staphylococcus aureus, Pseudomonas aeruginosa, Enterococcus faecalis*, coagulase-negative staphylococci, Enterobacteriaceae, anaerobic bacteria as well as group G β-hemolytic streptococci ([@B23]; [@B44]). Further, *P. aeruginosa* and, to a lower degree, *S. aureus* were shown to form most complex wound biofilms ([@B44]). Two or up to five species are detected by bacterial culture in three out of four chronic ulcers ([@B23]). *S. aureus* and *P. aeruginosa* are most frequently detected by culture-based approaches from chronic leg ulcers with comparable detection rates in bioptic samples and swab assessments ([@B24]).

However, molecular approaches allow a deeper insight in the microbial composition of chronic wound infections. Fluorescence *in situ* hybridization was shown to identify *P. aeruginosa* in biofilms in wounds even if culture-based diagnostic approaches failed due to difficult sampling conditions ([@B32]). The reason for this failing of culture-based approaches is that the spatial distance of *P. aeruginosa* aggregates from the wound surface is significantly bigger than for aggregates of the more frequently detected *S. aureus* ([@B15]). This could also explain the phenomenon of the greater importance of *P. aeruginosa* for keeping chronic wounds arrested in a stage of inflammatory processes ([@B15]) and for the larger size of *P. aeruginosa* containing ulcers ([@B23]). This is just one example how culture-based diagnostic approaches systematically underestimate the role of microorganisms in chronic wounds ([@B69]). As shown in animal experiments by next generation sequencing (NGS), facultative pathogenic microorganisms like staphylococci and streptococci, which are typically isolated from wound infections by traditional culture-based approaches, do not necessarily play a quantitatively prominent role in biofilms in case of surgical site infections, while species of Porphyromonadaceae, Deinococcaceae, Methylococcaceae, Nocardiaceae, Alteromonadaceae, and Propionibacteriaceae quantitatively dominated in these assessments ([@B34]).

Complex microbial community structure within chronic leg ulcers can be demonstrated in detail by 16S rRNA NGS and quantitative PCR (qPCR; [@B55]), but this approach is still too complex and expensive for the diagnostic routine. While the value of NGS and advanced bioinformatics for the characterization of chronic wounds is widely accepted, their impact on individual therapeutic management decisions which might justify their use in spite of considerable costs is still poorly assessed ([@B60]).

The Respiratory Tract
---------------------

### Proof of Multiple Respiratory Pathogens---Useful Diagnostic Information or Just More Confusion?

Various multiplex PCR assays are available for the diagnosis of upper respiratory infections and atypical pneumonia ([@B9]; [@B31]). Interpretative problems can arise from multiple pathogen detections in respiratory specimens. The focus is on the detection of treatable or hygienically relevant viruses such as influenza, adeno, or respiratory syncytial virus (RSV). The reason for screening for other viruses is the intention to reduce unnecessary antibiotic therapy ([@B47]). Further typical diagnostic indications comprise acute exacerbations of chronic lung diseases like cystic fibrosis (CF) and chronic obstructive pulmonary disease ([@B18],[@B19]; [@B40]).

The upper respiratory tract exhibits a high anatomical complexity with several ecological niches, e.g., the tonsillar crypts or the nasopharynx. Therefore, multiple pathogen detections are frequent in the upper respiratory tract. Multiple pathogens were detected on nasal swabs, in nasopharyngeal aspirates, or in nasal washing specimens of 46% ([@B41]), 43% ([@B27]) and 24.5% ([@B67]) assessed children with respiratory disease, respectively (see **Table [2](#T2){ref-type="table"}**).

###### 

Examples of studies demonstrating multiple pathogen detections by PCR in stool and respiratory samples.

  Study    Short study description                                                                                                                                                                                Number (%) of samples with different pathogens detected per sample
  -------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ----------------------------------------------------------------------------------------------------------------------------------------------------------------------
  [@B4]    PCR-based screening for 15 enteric pathogens in stool samples of altogether 312 pediatric patients with gastroenteritis and travelers with suspected parasite infestations in Switzerland              8 (2.6%) with two different pathogens
  [@B17]   PCR-based screening for 12 enteric pathogens in 410 stool samples of asymptomatic Madagascan children                                                                                                  5 (1.2%) with four different pathogens, 38 (9.3%) with three different pathogens, 38 (25.9%) with two different pathogens
  [@B20]   PCR-based screening for 17 enteric pathogens in 53 stool samples of European soldiers with diarrhea on deployment in Western African Mali                                                              1 (1.9%) with five different pathogens, 1 (1.9%) with four different pathogens, 9 (17.0%) with three different pathogens, 12 (22.6%) with two different pathogens
  [@B43]   PCR-based screening for eight enteric parasites in stool samples of four hundred 13-month-old children in rural Ecuador                                                                                1 (0.3%) with four different pathogens, 3 (0.8%) with three different pathogens, 30 (7.5%) with two different pathogens
  [@B27]   PCR-based screening for 10 viral and bacterial respiratory pathogens in nasopharyngeal aspirates of 82 infants with episodes of respiratory tract infections in the Netherlands                        13 (15.9%) with three different pathogens, 22 (26.8%) with two different pathogens
  [@B41]   PCR-based screening for 15 respiratory viruses and subtypes in nasal swabs in 455 incidents of respiratory illness in 225 childcare-attendees in the USA                                               4 (0.9%) with five different pathogens, 24 (5.3%) with four different pathogens, 54 (11.9%) with three different pathogens, 130 (28.6%) with two different pathogens
  [@B67]   qPCR-based screening for 17 viral and bacterial pathogens in nasal washing specimens obtained from 583 patients below 12 years of age with suspected acute respiratory infections in the Netherlands   3 (0.5%) with four different pathogens, 23 (4.0%) with three different pathogens, 114 (20.0%) with two different pathogens

Questions arise how to deal with such multiple pathogen detections and how to assign etiological significance. Some authors associate high pathogen load as determined by qPCR with clinical relevance ([@B27]). However, other factors are likely to play a role as well, comprising first of all clinical symptoms but also the kind of sample material and the assessed anatomical sites. In the exemplary case of co-incident rhinitis, pharyngitis, and bronchitis which may, by chance, be caused by distinct pathogens, a sample from the lower respiratory tract like pharyngeal lavage fluid will contain mechanically spread DNA or RNA of pathogens from all infected sites. In such a case, etiological relevance of different causative agents can exist irrespective of the measured pathogen load.

The Intestinal Tract
====================

The Interpretative Problem of Multiple Enteric Pathogen Detections in High Endemicity Settings
----------------------------------------------------------------------------------------------

In recent years, diagnostic tests for the detection of gastrointestinal pathogens have gradually shifted from microbiological methods like culture, microscopy, and antigen testing to multiplexed DNA-amplification procedures, with increased diagnostic sensitivity ([@B7]; [@B10]; [@B56]; [@B21]; [@B38]; [@B61]). These molecular methods comprise, e.g., PCR-Luminex, multiplex real-time qPCR, TaqMan array cards, microfluidic qPCR and Lab-on-a-chip devices ([@B1]; [@B33]; [@B13]; [@B57]; [@B59]). It was shown that the new methods facilitate diagnosis, infection control, and epidemiologic management. In some cases, it is still necessary to supplement them with other methods like resistance testing or bacterial culture ([@B4]). When a positive diagnostic result is obtained, antimicrobial therapy is usually adjusted to the identified pathogen and the associated resistance pattern and a favorable clinical course under appropriate antimicrobial treatment is considered to confirm the diagnostic result.

If, e.g., diagnostic multiplex PCR systems are applied with stool samples from patients usually living under conditions of high hygienic standards in Western industrialized societies, both asymptomatic colonization in apparently healthy individuals and the detection of multiple pathogens in symptomatic patients even in spite of short-term exposition in tropical settings are infrequent ([@B66]; [@B4]). The same applies for apparently healthy soldiers returning from tropical deployments who rarely show chronic infestations with protozoa if appropriate food and water hygiene precautions are enforced ([@B21]). In contrast, high detection rates of facultatively pathogenic microorganisms are observed in stool samples of both symptomatic patients and healthy individuals in settings of high endemicity ([@B8]; [@B43]; [@B38]; [@B20],[@B22]; [@B35]; [@B14]).

In such instances, any interpretative discrimination between asymptomatic colonization and clinically relevant infection becomes challenging and requires clinical experience ([@B48]; [@B20],[@B22]). The simultaneous detection of several enteric pathogens in stool samples of people living in high endemic regions impede the etiological attribution and makes an appropriate subsequent therapy, in case of severe diseases, challenging. The high risk of detecting traces of asymptomatic carriage or residual DNA of previous infections ([@B22]) limits the value of causal attribution of detected pathogens to infectious gastrointestinal disease (see **Table [2](#T2){ref-type="table"}**).

Because of this, the importance of the development of evaluated standards for the interpretation of molecular test results from stool samples should be emphasized, both for diagnostic routine and for epidemiological assessments. One option is semi-quantification by counting colony forming units or quantification of pathogen gene equivalents in stool material by qPCR, which is challenging in such complex material due to PCR inhibition ([@B22]).

In this regard, it is also important to refer to recent studies on colonization resistance. Differences in hygiene, diet, and lifestyle show severe impact on the dissemination of pathogens including the colonization of the gastrointestinal tract. Bereswill and colleagues examined the role of nutrition and obesity with regard to susceptibility to *Campylobacter jejuni* infections in gnotobiotic and obese mice and found out that host-specific intestinal microbiota play a key role in maintaining colonization resistance against *C. jejuni* ([@B5],[@B6]; [@B42]). Therefore, diet and microbiota composition are additional factors that interfere with the decision on etiological relevance.

Multi-Drug Resistant Bacteria in the Gut---Harmless Colonizers or "Enteric Time-Bomb"?
--------------------------------------------------------------------------------------

Exposure to antibiotics crucially contributes to the emergence of resistance, supporting the concept of the resistome, i.e., the collection of all antibiotic resistance genes in a specific niche such as the gut ([@B53]; [@B36]; [@B12]). Recent metagenomic studies have shown an unexpectedly high diversity and abundance in the microbiota of the gut and revealed a close relation to the consumption of antibiotics ([@B16]; [@B28]). [@B28] examined the intestinal microbiome of individuals from Denmark, Spain, and China and compared these data to agricultural and environmental data sets. Individuals from China exhibited the highest diversity of resistance genes (70 types of resistance genes in more than 50% of tested individuals) in the gut microbiome, individuals from Denmark the lowest (45 types of resistance genes in more than 50% of tested individuals) ([@B28]). The observed variations were associated with consumption of antibiotics. High numbers of resistance genes in Chinese individuals coincided with local overuse of antibiotics. The antibiotic resistance genes persisted in the human gut microbiota for a year and more, although such mutations may be accompanied by fitness costs ([@B16]; [@B12]).

However, multi-drug resistant (MDR) bacteria in the gut also have the ability to grow on selective media and possibly to overgrow other clinically relevant germs. Due to MDR-resistant Enterobacteriaceae, for example, screening for *Arcobacter* spp. in feces is extremely difficult. In addition, the question of hygiene measures arises in the case of unintended isolation of MDR-resistant Enterobacteriaceae. Over-diagnostics can be reduced by careful pre-analytic decisions on applied diagnostic approaches.

Methodical Issues
=================

Bacterial Culture---Screening of Multi-Drug Resistant Bacteria as an Example of Lacking Standardization of Cultural Approaches
------------------------------------------------------------------------------------------------------------------------------

Bacterial culture is prone to bias due to multiple colonization and infection. In patients with polymicrobial bacteremia, the risk of dying is virtually identical as in patients with only one detectable pathogen in blood culture ([@B50]). Allocation of etiological relevance is difficult in such instances.

In contrast, culture-based identification of certain bacterial pathogens with specific pathogenicity factors or resistance determinants within a complex bacterial colonization flora is even more challenging. This is the case, e.g., for the identification of diarrheagenic *Escherichia coli* among non-pathogenic *E. coli* in stool samples and for the detection of *P. aeruginosa* strains with special resistance determinants in respiratory samples of patients with CF or bronchiectasis, where several strains of the same species are frequently present ([@B58]; [@B40]). The usual approach is picking of several colonies for further assessment. However, this is very laborious and may fail if the strain of interest represents only a small proportion of the mixed bacterial flora.

The lack of standardization of screening assays targeting MDR bacteria, that means the lack of optimization and adaptation of diagnostic test assays in a way that they reproducibly lead to the same results with identical samples, is problematic. While swabbing techniques and the kind of used swabs affect the sensitivity of screening for MRSA ([@B3]; [@B63],[@B64],[@B65]), even basal questions like the need for broth enrichment ([@B46]; [@B29]), required assessment strategies, and the number of samples ([@B26]; [@B62]; [@B52]; [@B2]) are under debate for screening for colonizers of the gut like vancomycin-resistant *Enterococcus* spp. or beta-lactam-resistant Enterobacteriaceae.

Further, detection rates of enteric colonization with extended spectrum beta-lactamase (ESBL) positive Enterobacteriaceae are affected by external factors. Gastrointestinal disorders like travelers' diarrhea and antibiotic therapies with associated selection pressure were shown to increase the likelihood of identifying enteric colonization with ESBL-positive Enterobacteriaceae in returning travelers ([@B30]). Return to Western industrialized countries leads to a decrease of enteric colonization with ESBL-positive Enterobacteriaceae below the detection threshold within months ([@B51]) due to reconstitution of the microbiome of the gut in the absence of interfering factors. In case of persistence in the gut below the detection threshold, screening at hospital admission for pre-existing enteric colonization with resistant bacteria prior to the onset of selecting factors like antibiotic therapy may fail. This makes the definite discrimination of endogenous infections from nosocomial transmissions difficult.

Molecular Diagnostics---On Interpretative Limitations of Diagnostic PCR
-----------------------------------------------------------------------

If multiple facultatively pathogenic microorganisms with potential etiological relevance are detected, the attribution of their pathogenic role for the disease of the respective patient is challenging. Quantitative or semi-quantitative approaches in qPCR may overcome this problem, assuming that high pathogen loads are associated with etiological relevance while low quantities indicate mere colonization.

[@B37] were able to show that high copy numbers (more than 10,000 within the qPCR reaction) of the *ipaH* gene that can be found in case of enteric infections with *Shigella* spp. or enteroinvasive *E. coli* in stool samples are considerably more often associated with clinical disease as well as with cultural confirmation of *Shigella* spp. and blood in stool samples than lower copy numbers. The researchers observed a 5.6-fold increase of diarrhea in cases with more than 29,000 gene copies and suggested a diagnostic cut-off of 14,000 copies.

In a large study comprising 867 stool samples from patients with diarrhea and 619 samples from volunteers without diarrhea that were assessed with three PCR platforms targeting altogether 15 enteric pathogens, [@B38] observed higher copy numbers of pathogens in symptomatic than in asymptomatic patients for the most assessed pathogens and test systems. In detail, this quantitative difference was significant for all 15 assessed pathogens using TaqMan array cards, for 14 out of 15 pathogens using a traditional real-time PCR approach (exemption: sapovirus) and for 12 out of 15 pathogens using PCR-Luminex (exemptions: adenovirus, norovirus, *Giardia* spp.).

[@B27] reported a negative correlation between the cycle threshold (ct) values of RSV PCR and clinical disease in infants with respiratory tract infections.

Studies by other authors were, however, less convincing. [@B48] detected significantly increased copy numbers of enteric pathogens for rotavirus and *Shigella* spp./enteroinvasive *E. coli* but not for eight other assessed etiologically relevant microorganisms in symptomatic patients. Very low ct-values as low as 14 in qPCR for enteric pathogens were observed in an assessment with stool samples from clinically healthy children in the Madagascan highlands ([@B20]). In an assessment of European soldiers with diarrhea in Mali, low ct values were observed for different pathogens in some cases of multiple pathogen detections, making any attribution of etiological relevance challenging ([@B22]).

Discussion
==========

The combined pathogenicity of multi-species biofilms is believed to maintain the inflammatory activity of chronic infections ([@B54]). However, for respiratory tract infections and gastrointestinal infections, attribution of etiological relevance is challenging in case of multiple detections of facultatively pathogenic microorganisms by diagnostic molecular multiplex approaches. The use of ct values of real-time PCR for semi-quantification and quantity-based estimation of etiological relevance has been suggested ([@B27]; [@B37]; [@B38]). However, only few definite cut-offs for quantitative interpretation have been proposed so far ([@B37]), and studies in high-endemicity settings suggest low ct values even in clinically healthy populations who live under conditions of high colonization pressure ([@B20]). Next to this, PCR approaches from stool samples are likely to be affected by PCR inhibition ([@B17]), making ct-value-based semi-quantification difficult. Further, ct-values vary depending on the applied PCR protocol ([@B22]), so quantitative standards are needed as internal controls. The quantitative interpretation of PCR-based approaches in primarily non-sterile samples materials is---in addition---affected by the detection of remaining nucleic acids from already cleared, previous infections or colonization. Considerable short-term stability of pathogen DNA and even RNA in various biological matrices has been demonstrated recently ([@B25]).

Although further standardization is necessary, the quantitative approach is promising. Recently, quantitative NGS with consecutive comparison with negative control samples, which was based on a specific subtraction of reads, was successfully applied for the etiological attribution of Shiga-toxin-producing *E. coli* as the causative agent in 67% stool samples of patients during an outbreak ([@B39]). Future studies will allow an appropriate standardization of such diagnostic approaches.
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